Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Invitrogen and Tecan have reported that they are entering into a collaboration agreement to validate the compatibility of Invitrogen's reagents with Tecan's microplate detection instruments.
Subscribe to our email newsletter
Invitrogen’s drug discovery products will be validated on selected Tecan microplate readers and instruments, starting with the Infinite series readers. Initial certifications will focus on Invitrogen’s assay systems for key target classes, such as LanthaScreen Tr-Fret for protein kinases, GeneBLAzer reporter-gene technology for G protein-coupled receptors. This collaboration will allow Tecan and Invitrogen to develop and promote joint applications for the drug discovery market.
John Printen, director of cell signaling at Invitrogen, said: “Through this partnership with Tecan, we will be able to provide integrated instrumentation and reagent solutions to the research community.”